Organigram Global Inc.
corporate_fare Company Profile
Organigram Global Inc. (NASDAQ:OGI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for OGI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-01, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 10/10, with 13 rated 8 or above. Recent SEC coverage for OGI spans 6-K, SCHEDULE 13D/A.
Recent high-impact activity:
- Full Sanity Earnout Amendment Agreements Filed, Including Related-Party Details
- Organigram Locks In Sanity Earnout at 85%, Unveils New Global Leadership
- Organigram Posts Record Q3 Revenue of $105.8M, Sanity Group Drives 49% Growth
- Organigram Posts Record Revenue, $105.5M Net Income in Q3; CFO Departs
- Organigram Reports Sanity on Track, Canadian Market Share Leadership Ahead of Q3 Results
Financial Snapshot
Insider Transactions
OGI files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.